Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
-21.91%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$7.78B
AUM Growth
-$2.41B
(-24%)
Cap. Flow
+$63.6M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
1,167
New
181
Increased
433
Reduced
358
Closed
174
Top Buys
| 1 |
Eli Lilly
LLY
|
$44.4M |
| 2 |
Travelers Companies
TRV
|
$40.9M |
| 3 |
American Homes 4 Rent
AMH
|
$36.8M |
| 4 |
Merck
MRK
|
$36.5M |
| 5 |
Synchrony
SYF
|
$31M |
Top Sells
| 1 |
Amazon
AMZN
|
$61.4M |
| 2 |
Willis Towers Watson
WTW
|
$49.9M |
| 3 |
SBA Communications
SBAC
|
$42.9M |
| 4 |
DuPont de Nemours
DD
|
$41.4M |
| 5 |
American Tower
AMT
|
$34.5M |
Sector Composition
| 1 | Technology | 22.82% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 14.24% |
| 4 | Consumer Discretionary | 10.76% |
| 5 | Communication Services | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRS
951
DELISTED
Antares Pharma, Inc.
ATRS
| $116K | ﹤0.01% |
49,100
-155,600
| -76% | -$368K |
|
952
Wave Life Sciences
WVE
$1.32B
| $112K | ﹤0.01% |
+11,976
| New | +$112K |
|
953
Aldeyra Therapeutics
ALDX
$334M
| $111K | ﹤0.01% |
44,963
+17,131
| +62% | +$42.3K |
|
954
Ecovyst
ECVT
$1.03B
| $111K | ﹤0.01% |
10,213
| – | – |
|
955
Tempest Therapeutics
TPST
$48.8M
| $111K | ﹤0.01% |
108
-89
| -45% | -$91.5K |
|
|
SYNC
956
DELISTED
Synacor, Inc.
SYNC
| $109K | ﹤0.01% |
106,882
| – | – |
|
|
NEOS
957
DELISTED
Neos Therapeutics, Inc
NEOS
| $107K | ﹤0.01% |
142,890
+21,138
| +17% | +$15.8K |
|
958
Atara Biotherapeutics
ATRA
$90.7M
| $105K | ﹤0.01% |
494
-829
| -63% | -$176K |
|
959
Titan International
TWI
$562M
| $99K | ﹤0.01% |
63,740
-180,621
| -74% | -$281K |
|
|
EGIO
960
DELISTED
Edgio, Inc. Common Stock
EGIO
| $94K | ﹤0.01% |
411
| – | – |
|
961
Kearny Financial
KRNY
$415M
| $90K | ﹤0.01% |
+10,492
| New | +$90K |
|
|
ATHX
962
DELISTED
Athersys, Inc. Common Stock
ATHX
| $88K | ﹤0.01% |
1,177
-7,900
| -87% | -$591K |
|
963
Cartesian Therapeutics
RNAC
$277M
| $86K | ﹤0.01% |
+1,187
| New | +$86K |
|
964
Tilly's
TLYS
$57.3M
| $82K | ﹤0.01% |
+19,835
| New | +$82K |
|
|
PMBC
965
DELISTED
Pacific Mercantile Bancorp
PMBC
| $82K | ﹤0.01% |
17,381
+2,135
| +14% | +$10.1K |
|
|
NPKI
966
NPK International Inc.
NPKI
$887M
| $80K | ﹤0.01% |
89,473
+62,812
| +236% | +$56.2K |
|
967
Solid Biosciences
SLDB
$428M
| $72K | ﹤0.01% |
+2,001
| New | +$72K |
|
968
IDEAYA Biosciences
IDYA
$2.38B
| $71K | ﹤0.01% |
17,311
-2,807
| -14% | -$11.5K |
|
969
Century Casinos
CNTY
$83.2M
| $68K | ﹤0.01% |
+28,237
| New | +$68K |
|
970
Kezar Life Sciences
KZR
$29.8M
| $67K | ﹤0.01% |
1,526
-7,484
| -83% | -$329K |
|
971
DigitalBridge
DBRG
$2.04B
| $66K | ﹤0.01% |
9,396
-3,872
| -29% | -$27.2K |
|
|
KIN
972
DELISTED
Kindred Biosciences, Inc.
KIN
| $64K | ﹤0.01% |
+16,038
| New | +$64K |
|
|
CBAY
973
DELISTED
Cymabay Therapeutics
CBAY
| $63K | ﹤0.01% |
42,600
-174,009
| -80% | -$257K |
|
|
INN
974
Summit Hotel Properties
INN
$614M
| $61K | ﹤0.01% |
+14,503
| New | +$61K |
|
975
Valhi
VHI
$461M
| $61K | ﹤0.01% |
+4,898
| New | +$61K |
|